Matrix metalloproteinase-2 expression correlates with morphological and immunohistochemical epithelial characteristics in synovial sarcoma

Histopathology

Volumn 40, Issue 3, 2002, Pages 279-285

  Saito, T ^a   Oda, Y ^a   Sakamoto, A ^a   Tamiya, S ^a   Iwamoto, Y ^a   Tsuneyoshi, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

E cadherin; Epithelial morphology; Immunohistochemistry; Matrix metalloproteinase 2; Synovial sarcoma

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 7; CYTOKERATIN 8; GELATINASE A; UVOMORULIN;

ARTICLE; CELL DIFFERENTIATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOSKELETON; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SYNOVIAL SARCOMA; TUMOR CELL;

CADHERINS; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MATRIX METALLOPROTEINASE 2; SARCOMA, SYNOVIAL;

EID: 0036120137     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01345.x     Document Type: Article

References (32)

1. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma
2. Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-met correlates with poor prognosis in synovial sarcoma
3. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma
4. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome
5. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma
6. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localized in nuclear bodies
7. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins
8. KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas
9. Prognostic value of the preserved expression of E-cadherin and catenin families of adhesion molecules and of β-catenin mutation in synovial sarcoma
10. Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis
11. Matrix metalloproteinases
12. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer
13. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
14. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
15. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells
16. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
17. Cytokeratin subunits of inclusion bodies in rhabdoid cells: Immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma
18. Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral sheath tumor
19. Coexpression of vimentin and keratins by human melanoma tumor cells: Correlation with invasive and metastatic potential
20. Control of cell motility and tumor invasion by extracellular matrix interactions
21. Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells
22. Gelatinases of murine metastatic tumor cells
23. CD44 isoform expression in synovial sarcoma correlates with epitheliogenesis but not prognosis
24. CD44 is the principle cell surface receptor for hyaluronate
25. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits
26. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
27. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody
28. A link between ras and metastatic behaviour of tumor cells: Ras induces CD44 promoter activity and leads to low-level expression of metastases-specific variants of CD44 in CREF cells
29. De-novo expression of CD44 and survival in gastric cancer
30. Expression of a CD44 variant containing exons 8-10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients
31. CD44 - A new prognostic marker for neuroblastoma
32. E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features